Overview
Pediatric onset Sjögren syndrome is a rare autoimmune disorder characterized by lymphocytic infiltration of exocrine glands, leading to symptoms such as dry eyes and mouth, along with systemic manifestations like arthritis and lymphadenopathy 1.Diagnosis
Clinical Criteria: Presence of oral and ocular dryness, often accompanied by systemic symptoms like fever, fatigue, and joint pain 1.
Laboratory Tests: Elevated anti-nuclear antibodies (ANA), positive anti-SSA/Ro or anti-SSB/La antibodies, and low salivary flow or Schirmer's test scores 1.
Imaging and Biopsy: Salivary gland imaging (e.g., sialogram) showing abnormalities, and salivary gland biopsy revealing lymphocytic infiltration 1.Management
First-Line Treatments:
- Corticosteroids: Initial management often involves low to moderate dose corticosteroids to control inflammation 1.
- Immunosuppressive Agents: Mycophenolate mofetil or methotrexate may be used for refractory cases 1.
Adjunctive Treatments:
- Artificial Tears and Saliva Substitutes: To manage dry eyes and mouth symptoms 1.
- Symptomatic Relief: Analgesics for joint pain and other discomforts 1.Special Populations
Pediatric Considerations: Limited specific pediatric data; management often mirrors adult protocols with careful monitoring for growth and development 1.
Comorbidities: Management may need adjustment in presence of coexisting autoimmune conditions or systemic involvement 1.Key Recommendations
Early Recognition and Multidisciplinary Approach: Early diagnosis and involvement of rheumatology specialists are crucial for effective management (Evidence: Expert opinion 1).
Use of Corticosteroids for Inflammatory Control: Initiate with corticosteroids for managing acute inflammatory symptoms (Evidence: Expert opinion 1).
Monitor for Systemic Involvement: Regular assessment for systemic manifestations and organ involvement, especially in pediatric patients (Evidence: Expert opinion 1).
Consider Immunosuppressive Therapy for Refractory Cases: Transition to immunosuppressive agents like mycophenolate mofetil if corticosteroids are insufficient (Evidence: Expert opinion 1).References
1 LaRusso M, Gallego-Pérez DF, Abadía-Barrero CE. Untimely care: How the modern logics of coverage and medicine compromise children's health and development. Social science & medicine (1982) 2023. link
2 Elilarasi S, Poovazhagi V, Kumaravel G, Srividya VG, Solomon JRS. Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2. Indian journal of pediatrics 2022. link
3 Rosen P, Spalding SJ, Hannon MJ, Boudreau RM, Kwoh CK. Parent satisfaction with the electronic medical record in an academic pediatric rheumatology practice. Journal of medical Internet research 2011. link